The FDA has granted 510(k) clearance to binx io (binx health) for women’s health, a molecular point-of-care diagnostic testing platform for detecting chlamydia and gonorrhea in approximately 30 minutes.
The World Health Organization (WHO) has updated the WHO Model List of Essential Medicines for 2019.
Preliminary evidence suggests some benefit with statins.
The FDA has granted Breakthrough Device designation to ResistancePlus GC (SpeeDx), a test that detects ciprofloxacin susceptibility and provides resistance information to aid in the treatment of gonorrhea.
Heritage Pharmaceuticals has initiated a voluntary recall of Amikacin Sulfate Injection, USP, 1g/4mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP, 10mg/2mL (5mg/mL) after microbial growth was detected in 1 unreleased sublot of both products.
Gentamicin should generally not be considered a first-line option in the treatment of gonorrhea, however it may be useful in certain patients, according to the results of a recent non-inferiority trial.
The final rule states that certain active ingredients are not allowed to be used in OTC hand sanitizers, which are meant for use without water and soap.
These findings were significant in hog farmers and their households in North Carolina.
Recently, New York Giants wide receiver Daniel Fells was diagnosed with a methicillin-resistant Staphylococcus aureus (MRSA) infection. Fells has since been sidelined for the rest of the season. The Giants are taking aggressive precautions to stop the spread of infection among players, including conducting consultations with infectious disease specialists.
